Agenus Inc – Strategy, SWOT and Corporate Finance Report

Agenus Inc – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360Ëš view of the company.

Agenus Inc (Agenus) is a clinical-stage immuno-oncology company that discovers, develops and commercializes a wide range of immunotherapeutics for the treatment of various types of cancers and infectious diseases. The company’s pipeline portfolio encompasses vaccines for glioblastoma, genital herpes, and multiple cancer types; vaccine adjuvants for the treatment of shingles and malaria; and checkpoint antibodies targeted at various diseases. The company's technology portfolio includes antibody discovery platform, vaccine platforms and Heat Shock Protein (HSP) platform. The company has collaborations with several pharmaceutical companies such as GSK, Incyte, and Merck; and universities such as UC San Francisco and UW Seattle. It operates in the US and Europe. Agenus is headquartered in Lexington, Massachusetts, the US.

Scope

Detailed information on Agenus Inc required for business and competitor intelligence needs

A study of the major internal and external factors affecting Agenus Inc in the form of a SWOT analysis

An in-depth view of the business model of Agenus Inc including a breakdown and examination of key business segments

News about Agenus Inc, such as business expansion, restructuring, and contract wins

Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

Gain understanding of Agenus Inc and the factors that influence its strategies.

Track strategic initiatives of the company and latest corporate news and actions.

Assess Agenus Inc as a prospective partner, vendor or supplier.

Support sales activities by understanding your customers' businesses better.

Stay up to date on Agenus Incs business structure, strategy and prospects.

Note: Some sections may be missing if data is unavailable for the company.

Companies mentioned

Northwest Biotherapeutics Inc

Green Cross Cell Corp

TVAX Biomedical Inc

Celldex Therapeutics Inc

Oxford BioMedica Plc

Idera Pharmaceuticals Inc

Dynavax Technologies Corp

Juvaris BioTherapeutics Inc

ImmunoCellular Therapeutics Ltd

Table of Contents

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1 - About the Company

Agenus Inc - Key Facts

Agenus Inc - Key Employees

Agenus Inc - Key Employee Biographies

Agenus Inc - Major Products and Services

Agenus Inc - History

Agenus Inc - Company Statement

Agenus Inc - Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Section 2 Company Analysis

Company Overview

Agenus Inc - Business Description

Geographical Segment: Europe

Performance

Geographical Segment: United States

Performance

Agenus Inc - Corporate Strategy

Agenus Inc - SWOT Analysis

SWOT Analysis - Overview

Agenus Inc - Strengths

Agenus Inc - Weaknesses

Agenus Inc - Opportunities

Agenus Inc - Threats

Agenus Inc - Key Competitors

Section 3 Company Financial Ratios

Financial Ratios - Capital Market Ratios

Financial Ratios - Annual Ratios

Performance Chart

Financial Performance

Financial Ratios - Interim Ratios

Financial Ratios - Ratio Charts

Section 4 Company’s Lifesciences Financial Deals and Alliances

Agenus Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Agenus Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

Agenus Inc, Recent Deals Summary

Section 5 Company’s Recent Developments

Mar 21, 2019: Agenus announces clinical appointments

Mar 14, 2019: Agenus reports fourth quarter and full year 2018 financial results and provides corporate update

Feb 19, 2019: Agenus Launches First Asset-Backed Digital-Security Offering in Healthcare

Nov 13, 2018: Agenus names Dr.Allison Jeynes-Ellis as new board member and Dr. Jennifer Buell as Chief Operating Officer

Oct 09, 2018: Agenus To Present Data on Proprietary CTLA-4 & PD-1 Antibodies at ESMO 2018

Oct 08, 2018: Agenus Increases GMP Manufacturing Capabilities at its Berkeley Facility, US

Sep 05, 2018: AgenTus Therapeutics to present on the Anti-tumor Activities of two proprietary T Cell receptors (TCRs) at CAR-TCR Summit in Boston, MA

Aug 09, 2018: Agenus reports second quarter 2018 financial results and provides corporate update

Jul 16, 2018: Agenus names regulatory and clinical heads

Jun 30, 2018: Agenus reports third quarter 2018 financial results and provides corporate update

Section 6 Appendix

Methodology

Ratio Definitions

About GlobalData

Contact Us

Disclaimer

List of Tables

List of Tables

Agenus Inc, Key Facts

Agenus Inc, Key Employees

Agenus Inc, Key Employee Biographies

Agenus Inc, Major Products and Services

Agenus Inc, History

Agenus Inc, Subsidiaries

Agenus Inc, Key Competitors

Agenus Inc, Ratios based on current share price

Agenus Inc, Annual Ratios

Agenus Inc, Annual Ratios (Cont…1)

Agenus Inc, Interim Ratios

Agenus Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Agenus Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

Agenus Inc, Recent Deals Summary

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

List of Figures

List of Figures

Agenus Inc, Performance Chart (2014 – 2018)

Agenus Inc, Ratio Charts

Agenus Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Agenus Inc, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019

    Pricing

Discounts available for multiple report purchases.

reportstore@marketline.com
+44 (0) 161 359 5817

Saved reports